Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 11, 1996, Pages 3902-3908

  Boguszewski, Margaret ^a,b   Jansson, Chatarina ^a   Rosberg, Sten ^a   Albertsson Wikland, Kerstin ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; CHILD; DIAGNOSTIC VALUE; FEMALE; GROWTH RETARDATION; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREPUBERTY; PRIORITY JOURNAL; SCORING SYSTEM; SHORT STATURE; SMALL FOR DATE INFANT; SUBCUTANEOUS DRUG ADMINISTRATION;

ABNORMALITIES, MULTIPLE; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; FEMALE; FETAL GROWTH RETARDATION; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; REGRESSION ANALYSIS; SYNDROME;

EID: 0029820179     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.11.3902     Document Type: Article

References (33)

1. Tenovuo A, Kero P, Piekkala P, Korvenranta H, Sillanpää M, Erkkola R. 1987 Growth of 519 small for gestational age infants during the first two years of life. Acta Paediatr Scand. 76:636-646.
2. Karlberg J, Albertsson-Wikland K. 1995 Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res. 38:733-739.
3. Chaussain JL, Colle M, Ducret JP. 1994 Adult height in children with prepubertal short stature secondary to intrauterine growth retardation. Acta Paediatr. 399(Suppl):72-73.
4. Davies PSW, Valley R, Preece MA. 1988 Adolescent growth and pubertal progression in the Silver-Russell syndrome. Arch Dis Child. 63:130-135.
5. Barker DJP. 1993 The intrauterine origins of cardiovascular disease. Acta Paediatr. 391(Suppl):93-99.
6. Boguszewski M, Rosberg S, Albertsson-Wikland K. 1995 Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children. J Clin Endocrinol Metab. 80:2599-2606.
7. de Waal WJ, Hokken-Koelega ACS, Stijnen Th, de Muinck Keizer-Schrama SMPF, Drop SLS, Dutch Working Group on Growth Hormone. 1994 Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. Clin Endocrinol (Oxf). 41:621-630.
8. Lassarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M. 1991 Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus: relationship with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res. 29:219-225.
9. Giudice LC, de Zegher F, Gargosky SE, et al. 1995 Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab. 80:1548-1555.
10. Thieriot-Prevost G, Boccara JF, Francoual C, Badoual J, Job JC. 1988 Serum insulin-like growth factor I and serum growth-promoting activity during the first postnatal year in infants with intrauterine growth retardation. Pediatr Res. 24:380-383.
11. Mandel S, Moreland E, Nichols V, Hanna C, Lafranchi S. 1995 Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment. J Clin Endocrinol Metab. 80:190-194.
12. Albertsson-Wikland K, Hall K. 1987 Growth hormone treatment in short children: relationship between growth and serum insulin-like growth factor I and II levels. J Clin Endocrinol Metab. 65:671-678.
13. Chatelain P, Job JC, Blanchard J, et al. 1994 Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth-retarded children. J Clin Endocrinol Metab. 78:1454-1460.
14. Chaussain JL, Colle M, Landier F. 1994 Effects of growth hormone therapy in prepubertal children with short stature secondary to intrauterine growth retardation. Acta Paediatr Scand. 399(Suppl):74-75.
15. Karlberg J, Fryer JG, Engström I, Karlberg P. 1987 Analysis of linear growth using a mathematical model. II. From 3 to 21 years of age. Acta Paediatr Scand. 337(Suppl):12-29.
16. Niklasson A, Ericson A, Fryer J, Karlberg J, Lawrence C, Karlberg P. 1991 An update of the Swedish Reference Standards tor weight, length and head circumference at birth for given gestational age (1977-1981). Acta Paediatr Scand. 80:756-762.
17. Karlberg P, Taranger J, Engström I, Lichtenstein H, Svennberg-Redegren I. 1976 The somatic development of children in a Swedish urban community. Acta Paediatr Scand. 258(Suppl):1-88.
18. Blum WF, Breier BH. 1994 Radioimmunoassays for IGFs and IGFBPs. Growth Regul. 4:11-19.
19. Bradley JV. 1968 Distribution of free statistical tests. London: Prentice-Hall; 68-86.
20. Mantel N. 1963 Chi-square tests with one degree of freedom. Jasa. 58:690-700.
21. Box GEP, Cox DR. 1964 Analysis of transformations. J R Stat Med. Ser. B. 26:211-252.
22. D'Ercole AJ. 1992 The insulin-like growth factors and in utero growth. Growth Genet Horm. 8:1-5.
23. Fant M, Salafia C, Baxter RC, et al. 1993 Circulating levels of IGFs and IGF binding proteins in human cord serum: relationships to intrauterine growth. Regul Pept. 48:29-39.
24. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB. 1993 Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein-3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab. 76:1610-1616.
25. Smith WJ, Nam TJ, Underwood LE, Busby WH, Celnicker A, Clemmons DR. 1993 Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and ICF-I for assessing growth hormone status in short children. J Clin Endocrinol Metab. 77:1294-1299.
26. Rosenfeld RG, Kemp SF, Hintz RL. 1981 Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate. J Clin Endocrinol Metab. 53:611-617.
27. Ranke MB, Blum WF, Bierich JR. 1988 Clinical relevance of serum measurements of insulin-like growth factors and somatomedin binding proteins. Acta Paediatr Scand. 347(Suppl):114-126.
28. Juul A, Dalgaard P, Blum WF, et al. 1995 Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP- 1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab. 80:2534-2542.
29. Albanese A, Stanhope R. 1993 Growth and metabolic data following growth hormone treatment of children with intrauterine growth retardation. Horm Res. 39:8-12.
30. de Zegher F, Maes M, Heinrichs C, et al. 1994 High-dose growth hormone therapy for short children born small for gestational age. Acta Paediatr. 399(Suppl):77-78.
31. Kriström B, Karlberg J, Albertsson-Wikland K, Swedish Paediatric Study Group for GH treatment. 1995 Prediction of the growth response of short prepubertal children treated with growth hormone. Acta Paediatr. 84:51-57.
32. Spagnoli A, Spadoni GL, Cianfarani S, Pasquino AM, Troiani S, Boscherini B. 1995 Prediction of the outcome of growth hormone therapy in children with idiopathic short stature. A multivariate discriminant analysis. J Pediatr. 126:905-909.
33. Ranke MB, Guilband O, Lindberg A, Cole T on behalf of the International Board of the Kabi Pharmacia International Growth Study. 1993 Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. Acta Paediatr, 391(Suppl):82-88.